PZE
piperazine
Created: | 2011-02-01 |
Last modified: | 2011-06-04 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 16 |
Chiral Atom Count | 0 |
Bond Count | 16 |
Aromatic Bond Count | 0 |
Chemical Component Summary | |
---|---|
Name | piperazine |
Systematic Name (OpenEye OEToolkits) | piperazine |
Formula | C4 H10 N2 |
Molecular Weight | 86.136 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | N1CCNCC1 |
SMILES | CACTVS | 3.370 | C1CNCCN1 |
SMILES | OpenEye OEToolkits | 1.7.0 | C1CNCCN1 |
Canonical SMILES | CACTVS | 3.370 | C1CNCCN1 |
Canonical SMILES | OpenEye OEToolkits | 1.7.0 | C1CNCCN1 |
InChI | InChI | 1.03 | InChI=1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2 |
InChIKey | InChI | 1.03 | GLUUGHFHXGJENI-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB00592 |
---|---|
Name | Piperazine |
Groups |
|
Description | Piperazine is an organic compound that consists of a six-membered ring containing two opposing nitrogen atoms. First used as a solvent for uric acid, the use of piperazine as an anthelmintic agent was first introduced in 1953. Upon entry into the systemic circulation, the drug is partly oxidized and partly eliminated as an unchanged compound. Outside the body, piperazine has a remarkable power to dissolve uric acid and producing a soluble urate, but in clinical experience it has not proved equally successful. Piperazine was first introduced as an anthelmintic in 1953. Piperazine compounds mediate their anthelmintic action by generally paralyzing parasites, allowing the host body to easily remove or expel the invading organism. |
Synonyms |
|
Brand Names |
|
Indication | Used as alternative treatment for ascariasis caused by <i>Ascaris lumbricoides</i> (roundworm) and enterobiasis (oxyuriasis) caused by <i>Enterobius vermicularis</i> (pinworm). It is also used to treat partial intestinal obstruction by the common roundworm, a condition primarily occurring in children. |
Categories |
|
ATC-Code | P02CB01 |
CAS number | 110-85-0 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Gamma-aminobutyric acid receptor subunit beta-3 | MWGLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDKLLKGYDI... | unknown | agonist |
Cytochrome P450 2D6 | MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD... | unknown | substrate |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 4837 |
ChEMBL | CHEMBL1412 |
ChEBI | CHEBI:28568 |
CCDC/CSD | AKUFOB, AFIGED, AGIPZM, ANUSIO |
COD | 2102303, 2102695 |